Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-mediated Rejection in Kidney Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01134510
What this trial is testing

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Who this might be right for
Kidney Transplantation
Stanley Jordan, MD 20
Not applicableLooking for participantsNCT07663669
What this trial is testing

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
Centre Hospitalier Universitaire de Besancon 31
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableStudy completedNCT02294032
What this trial is testing

The Role of B Cells in Kidney Allograft Dysfunction

Who this might be right for
Kidney; Complications, AllograftTransplantation Infection
Loma Linda University 180
Not applicableNot Yet RecruitingNCT07718308
What this trial is testing

CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAntibody-mediated Rejection
wujianyong 20
Not applicableLooking for participantsNCT07081126
What this trial is testing

Daratumumab for Late Antibody-Mediated Rejection

Who this might be right for
Kidney TansplantAcute Rejection (AR) of Transplanted Kidney
University Hospital, Martin 20
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Not applicableStudy completedNCT04541914
What this trial is testing

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

Who this might be right for
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Seoul National University Hospital 30
Not applicableStudy completedNCT04851145
What this trial is testing

Mass Spectrometry-based Proteomics in Microvascular Inflammation Diagnosis in Kidney Transplantation.

Who this might be right for
Kidney TransplantationGraft RejectionHumoral Immunity+1 more
University Hospital, Bordeaux 141
Very early researchEnded earlyNCT03380936
What this trial is testing

Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
University of Colorado, Denver 4
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Post-approval studies (Phase 4)WithdrawnNCT02130817
What this trial is testing

Belatacept in Kidney Transplantation of Moderately Sensitized Patients

Who this might be right for
End Stage Renal DiseaseAntibody Mediated Rejection
University of Wisconsin, Madison
Not applicableEnded earlyNCT02120482
What this trial is testing

Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Who this might be right for
Decreased Immunologic ActivityAntibody-mediated Rejection
Medical University of Vienna 4
Early research (Phase 1)Study completedNCT05456243
What this trial is testing

Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Mayo Clinic 8
Not applicableStudy completedNCT04026087
What this trial is testing

Subclass of Donor-specific Antibody as a Risk Factor of Antibody Mediated Rejection in Renal Transplantation

Who this might be right for
Antibody-mediated Rejection
University Hospital, Montpellier 100
Large-scale testing (Phase 3)Study completedNCT00275509
What this trial is testing

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Who this might be right for
Kidney Failure, Chronic
Johns Hopkins University 56
Not applicableStudy completedNCT04897438
What this trial is testing

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

Who this might be right for
Kidney Transplant RejectionAntibody-mediated RejectionKidney Transplant Failure
Charite University, Berlin, Germany 40
Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Next Page